Macular Hole
39
2
4
24
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
3 terminated out of 39 trials
88.9%
+2.4% vs benchmark
10%
4 trials in Phase 3/4
8%
2 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (39)
Retinal Clinical Assessment With AI-derived Quantitative Information
Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent
UNITY VCS Vitreoretinal Surgery
No Endotamponade for Macular Hole Repair: the NEMAR Study
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Head Position Monitoring After Pars Planar Vitrectomy
Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
Minimal Vitrectomy and ILM Flap with Sodium Hyaluronate Gel for MH
PIONEER: Intraoperative and Perioperative OCT Study
Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery
Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter
Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes
Fourier Transformed Infrared Spectroscopy in Macular Surgery
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
Objective Evaluation of Postoperative Positioning in Macular Hole Surgery
Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Analysis of Aqueous and Vitreous Humor
Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery